Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma.

Trial Profile

Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs Pegargiminase (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2010 Results reported at American Society of Clinical Oncology (ASCO) meeting, according to a Polaris media release.
    • 07 Dec 2008 Planned end date changed from 1 Dec 2008 to 1 Dec 2010, according to ClinicalTrials.gov.
    • 19 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top